PTC Therapeutics, Inc.
News
PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
PR Newswire PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PTC Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) PR Newswire WARREN, N.J., Sept. 12...\n more…
PTC Therapeutics (NASDAQ:PTCT investor five-year losses grow to 27% as the stock sheds US$153m this past week
Simply Wall St Research PTC Therapeutics' (Nasdaq:PTCT) stock price, latest news & stock analysis. Find everything from its Valuation, Future Growth, Past Performance and more.\n more…
PTC Therapeutics (NASDAQ:PTCT) Raised to "Strong-Buy" at Baird R W
Ticker Report Baird R W upgraded shares of PTC Therapeutics (NASDAQ:PTCT - Free Report) to a strong-buy rating in a report published on Wednesday morning, Zacks.com reports. A number of other equities analysts...\n more…
PTC Therapeutics (NASDAQ:PTCT) Coverage Initiated by Analysts at Robert W. Baird
Ticker Report Robert W. Baird assumed coverage on shares of PTC Therapeutics (NASDAQ:PTCT - Free Report) in a research report sent to investors on Wednesday morning, Marketbeat Ratings reports. The firm issued an...\n more…
Panagora Asset Management Inc. Has $9.64 Million Position in PTC Therapeutics, Inc. (NASDAQ:PTCT)
Zolmax Panagora Asset Management Inc. increased its stake in shares of PTC Therapeutics, Inc. (NASDAQ:PTCT - Free Report) by 9.1% in the 2nd quarter, according to the company in its most recent Form 13F...\n more…
PTC Therapeutics to Participate at Upcoming Investor Conferences
PR Newswire PTC Therapeutics to Participate at Upcoming Investor Conferences PTC Therapeutics to Participate at Upcoming Investor Conferences PR Newswire WARREN, N.J., Aug. 28, 2024 WARREN, N.J., Aug. 28, 2024...\n more…